Back to results
US 12,049,516 B2Granted
Transgenic mammals and methods of use thereof
AssigneeTrianni, Inc.
InventorMatthias Wabl
Life of this patent
Estimating the term…
Abstract
The present invention relates to transgenic mammals that express canine-based immunoglobulins, including transgenic rodents that express canine-based immunoglobulins for the development of canine therapeutic antibodies.
Claims5
A method of producing antibodies comprising fully canine heavy and/or light chain variable domains and mouse constant domains, the method comprising:
- (i) providing a transgenic mouse with a genome in which an entire endogenous immunoglobulin variable gene locus has been deleted and replaced with an engineered partly canine immunoglobulin locus comprising canine immunoglobulin variable gene VH, D and JH and/or canine VL and JL coding sequences and mouse immunoglobulin variable gene locus non-coding regulatory sequences, wherein the engineered partly canine immunoglobulin locus of the transgenic mouse is functional and expresses immunoglobulin chains comprised of canine variable domains and mouse constant domains;
- and
- (ii) isolating the antibodies comprising canine variable regions and mouse constant regions expressed by the transgenic mouse.
Dependencies are inferred from the claim text.